Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome
Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Preconceptional use of low molecular weight heparin (enoxaparin) and aspirin in patient with
recurrent miscarriages with positive anti phospholipid antibodies increase the implantation
rate and the duration of pregnancy with low complications to the mother and the baby.